Lenvatinib Mesylate and Secukinumab Subcutaneous
Determining the interaction of Lenvatinib Mesylate and Secukinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Secukinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Secura Antifungal
- Lenvatinib Mesylate-Secura Antifungal Extra Thick
- Lenvatinib Mesylate-Secura Antifungal Topical
- Lenvatinib Mesylate-Seebri
- Lenvatinib Mesylate-Seebri Neohaler
- Lenvatinib Mesylate-Seebri Neohaler inhalation
- Secukinumab Subcutaneous-Lenvima
- Secukinumab Subcutaneous-Lenvima (14 MG Daily Dose)
- Secukinumab Subcutaneous-Lenvima (18 MG Daily Dose)
- Secukinumab Subcutaneous-Lenvima (20 MG Daily Dose)
- Secukinumab Subcutaneous-Lenvima (24 MG Daily Dose)
- Secukinumab Subcutaneous-Lenvima (8 MG Daily Dose)